|
Date |
Total[%] |
Ratings |
Cases |
Aug/00
Nov/00
Mar/02
Aug/05 |
17[5.9%]
17[11.8%]
14[28.6%]
19[57.9%] |
*(12)**(01)***(03)****(01)*****
*(10)** ***(05)****(02)*****
*(04)**(01)***(05)****(02)*****(02)
*(03)**(01)***(04)****(07)*****(04) |
Classification
and Coding |
Aug/00
Nov/00
Mar/02
Aug/05 |
8[0%]
10[10%]
10[10%]
11[18.2%] |
*(07)** ***(01)**** *****
*(07)**(01)***(01)**** *****(01)
*(06)**(01)***(02)****(01)*****
*(04)**(01)***(04)****(01)*****(01) |
Clinical
Discussion Forums |
Aug/00
Nov/00
Mar/02
Aug/05 |
10[40%]
9[44.4%]
11[45.4%]
15[40%] |
*(02)**(02)***(02)****(03)*****(01)
*(01)**(01)***(03)****(03)*****(01)
*(03)** ***(03)****(04)*****(01)
*(04)**(00)***(05)****(05)*****(01) |
Clinical Trials |
Aug/00
Nov/00
Mar/02
Aug/05 |
15[6.7%]
14[7.1%]
15[33.3%]
17[52.9%] |
*(05)**(04)***(05)****(01)*****
*(04)**(04)***(05)****(01)*****
*(03)**(01)***(06)****(01)*****(04)
*(03)**(00)***(05)****(04)*****(05) |
Decision Making
and Tools |
Aug/00
Nov/00
Mar/02
Aug/05 |
41[22%]
59[32.2%]
57[57.9%]
66[65.2%] |
*(17)**(10)***(05)****(05)*****(04)
*(17)**(10)***(13)****(10)*****(09)
*(07)**(04)***(13)****(08)*****(25)
*(06)**(05)***(12)****(12)*****(31) |
Diagnostics and
Therapeutics |
Aug/00
Nov/00
Mar/02
Aug/05 |
28[14.3%]
29[17.2%]
29[55.2%]
37[64.9%] |
*(12)**(04)***(08)****(02)*****(02)
*(11)**(03)***(10)****(03)*****(02)
*(04)**(02)***(07)****(11)*****(05)
*(02)**(02)***(09)****(13)*****(11) |
Disability |
Aug/00
Nov/00
Mar/02
Aug/05 |
9[0%]
11[0%]
6[33.3%]
15[33.3%] |
*(05)**(03)***(01)**** *****
*(05)**(03)***(03)**** *****
*(02)** ***(02)****(01)*****(01)
*(02)**(02)***(06)****(03)*****(02) |
Ethnic Medicine |
Aug/00
Nov/00
Mar/02
Aug/05 |
19[5.3%]
22[13.6%]
20[35%]
23[39.1%] |
*(12)**(05)***(01)****(01)*****
*(10)**(06)***(03)****(02)*****(01)
*(04)**(06)***(03)****(06)*****(01)
*(04)**(06)***(04)****(06)*****(03) |
Patient
Education |
Aug/00
Nov/00
Mar/02
Aug/05 |
117[36.8%]
115[39.1%]
152[32.9%]
134[41%] |
*(12)**(23)***(39)****(34)*****(9)
*(19)**(17)***(34)****(35)*****(10)
*(15)**(44)***(43)****(47)*****(03)
*(11)**(18)***(50)****(50)*****(05) |
Practice
Guidelines |
Aug/00
Nov/00
Mar/02
Aug/05 |
30[30%]
25[40%]
33[81.8%]
47[76.6%] |
*(08)**(06)***(07)****(05)*****(04)
*(04)**(06)***(05)****(05)*****(05)
*(02)** ***(04)****(09)*****(18)
*(05)**(01)***(05)****(10)*****(26) |
Prescription
Assistance Resources |
Aug/00
Nov/00
Mar/02
Aug/05 |
40[27.5%]
32[34.4%]
49[67.3%]
66[68.2%] |
*(07)**(15)***(07)****(07)*****(04)
*(04)**(09)***(08)****(07)*****(04)
*(06)**(03)***(07)****(12)*****(21)
*(08)**(07)***(07)****(24)*****(21) |
Rural Medicine |
Aug/00
Nov/00
Mar/02
Aug/05 |
14[7.1%]
15[6.7%]
14[7.1%]
16[12.5%] |
*(11)**(01)***(01)****(01)*****
*(11)**(01)***(02)****(01)*****
*(09)**(01)***(03)****(01)*****
*(08)**(01)***(05)****(02)*****(0) |